98视频精品全部国产,久久久久AV无码免费网

狠狠综合久久久久综合网,亚州少妇无套内射激情视频,成年免费A级毛片免费看丶,欧美熟妇色ⅩXXX欧美妇

鄭重說(shuō)明:

您值得信賴(lài)的中藥成分及標(biāo)準(zhǔn)合作伙伴滿足您研發(fā)和工業(yè)化需求

產(chǎn)品關(guān)鍵詞：香草酸-4-β-D-葡萄糖苷 6-甲氧基山奈酚茯苓新酸B 去甲異波爾定

guanyuwomen關(guān)于德思特

聯(lián)系方式

服務(wù)熱線：

028-8500-3950

公司傳真：	028-85589956
公司郵箱：	sales@tcmlmt.com
公司網(wǎng)址：	usemark.cn
公司地址：	四川省成都市溫江區(qū)?？坡肺鞫?28號(hào)5棟

發(fā)表文獻(xiàn)展示

當(dāng)前位置:首頁(yè)關(guān)于德思特 > 發(fā)表文獻(xiàn)展示 >

Evidence-Based Complementary and Alternative Medicine-20 Mar 2019 大黃素

時(shí)間：2020-09-03 瀏覽次數(shù)：分享到：

Pharmacokinetic and Bioavailability Studies of Embelin after Intravenous and Oral Administration to Rats
期刊名：Evidence-Based Complementary and Alternative Medicine
文獻(xiàn)編號(hào)：DOI 10.1155/2019/9682495
文獻(xiàn)地址：https://www.hindawi.com/journals/ecam/2019/9682495/
發(fā)表日期：20 Mar 2019

Abstract
Embelin exhibits the broad bioactivities such as antitumor, antifertility, antidiabetic, anti-inflammatory, antioxidant, anticonvulsant, anxiolytic, antimicrobial, and hepatoprotective activity. In order to further understand the pharmacokinetic characteristics and oral bioavailability of embelin in vivo, the concentration of embelin in rat plasma was determined by a sensitive high-performance liquid chromatography with diode array detector (HPLC-DAD). The preparation of samples was accomplished by a simple precipitating protein with methanol. Emodin was selected as the internal standard (IS). Embelin and IS were completely separated on an analytical column (Extend-C18, 4.6 × 250 mm, 5 μm) using 0.1% phosphoric acid in methanol and 0.1% phosphoric acid in aqueous solution (90:10, v/v) as the mobile phase. The lower limit of quantification was 0.15 μg/mL. Oral bioavailability of embelin was 30.2 ± 11.9%. This study could provide the information about pharmacokinetics and oral bioavailability of embelin, which was useful to assess the clinic efficacy and safety and promote further development of embelin.

Emodin was purchased from Chengdu Desite Biological Technology Co., Ltd. (Chengdu, China)

上一篇：Frontiers in pharmacology-09 January 2019 異槲皮苷穗花杉雙黃

下一篇：Journal of Separation Science-03 February 2018 綠原酸芍藥苷